In line with our previous findings [12], both CRC subgroups presented with increased numbers of HLA-DR+ CD4+ and CD8+ peripheral blood lymphocytes compared to healthy controls, which points to an unspecific activation in the context of malignancy. The gene discussed is CD4; the disease is colorectal carcinoma.